GANX
Price
$2.02
Change
-$0.20 (-9.01%)
Updated
Oct 7 closing price
Capitalization
79.81M
30 days until earnings call
OKUR
Price
$2.99
Change
+$0.17 (+6.03%)
Updated
Oct 7 closing price
Capitalization
40.45M
Interact to see
Advertisement

GANX vs OKUR

Header iconGANX vs OKUR Comparison
Open Charts GANX vs OKURBanner chart's image
Gain Therapeutics
Price$2.02
Change-$0.20 (-9.01%)
Volume$2.27M
Capitalization79.81M
OnKure Therapeutics
Price$2.99
Change+$0.17 (+6.03%)
Volume$322.56K
Capitalization40.45M
GANX vs OKUR Comparison Chart in %
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. OKUR commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and OKUR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (GANX: $2.02 vs. OKUR: $2.99)
Brand notoriety: GANX and OKUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 357% vs. OKUR: 323%
Market capitalization -- GANX: $79.81M vs. OKUR: $40.45M
GANX [@Biotechnology] is valued at $79.81M. OKUR’s [@Biotechnology] market capitalization is $40.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileOKUR’s FA Score has 0 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • OKUR’s FA Score: 0 green, 5 red.
According to our system of comparison, both GANX and OKUR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 5 TA indicator(s) are bullish while OKUR’s TA Score has 5 bullish TA indicator(s).

  • GANX’s TA Score: 5 bullish, 4 bearish.
  • OKUR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, OKUR is a better buy in the short-term than GANX.

Price Growth

GANX (@Biotechnology) experienced а +14.12% price change this week, while OKUR (@Biotechnology) price change was +8.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

GANX is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GANX($79.8M) has a higher market cap than OKUR($40.5M). GANX YTD gains are higher at: -6.481 vs. OKUR (-65.233). GANX has higher annual earnings (EBITDA): -17.16M vs. OKUR (-59.25M). OKUR has more cash in the bank: 83.4M vs. GANX (6.69M). GANX has less debt than OKUR: GANX (681K) vs OKUR (823K). GANX (0) and OKUR (0) have equivalent revenues.
GANXOKURGANX / OKUR
Capitalization79.8M40.5M197%
EBITDA-17.16M-59.25M29%
Gain YTD-6.481-65.23310%
P/E RatioN/A62.48-
Revenue00-
Total Cash6.69M83.4M8%
Total Debt681K823K83%
TECHNICAL ANALYSIS
Technical Analysis
GANXOKUR
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 1 day ago
64%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORPEF14.22N/A
N/A
Orpea ACT
MBRFF69.25N/A
N/A
Mo-Bruk SA
CWPS30.00N/A
N/A
Conwest Associates, L.P.
BDNNY84.59-1.07
-1.25%
Boliden AB
SRLZF0.11N/A
-2.44%
Salazar Resources Ltd.

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
-9.01%
COYA - GANX
39%
Loosely correlated
-1.69%
AXON - GANX
36%
Loosely correlated
-0.97%
ELVN - GANX
36%
Loosely correlated
-0.94%
EYPT - GANX
35%
Loosely correlated
-2.72%
MDGL - GANX
34%
Loosely correlated
-1.36%
More

OKUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, OKUR has been closely correlated with SRRK. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if OKUR jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKUR
1D Price
Change %
OKUR100%
+6.03%
SRRK - OKUR
90%
Closely correlated
-0.75%
ONCY - OKUR
25%
Poorly correlated
-0.74%
CUE - OKUR
23%
Poorly correlated
+3.42%
GANX - OKUR
22%
Poorly correlated
-9.01%
LQDA - OKUR
22%
Poorly correlated
+5.10%
More